Imperial College Healthcare NHS Trust is one of only eight trusts in the country to test a range of new healthcare-associated infection (HCAI) technologies.
The eight 'showcase' trusts focus on the in-use value of HCAI technologies, primarily evaluating products that are classified as category 1 by the Health Protection Agency's rapid review panel (RRP), which means the technologies should have benefits for NHS organisations.
Working with the NHS Technology Adoption Centre, we develop technical and economic business cases for each of the technologies. We gain invaluable knowledge about the practical aspects of using the products in real situations. We are then able to share our experiences, ranging from training needs and getting the products adopted, through to patient experiences.
The NHS Purchasing and Supply Agency (PASA) will then get expert feedback from the showcase trusts and work with the trusts' hospitals to make the most successful products more widely available.
At Imperial College Healthcare NHS Trust, we have tested the effectiveness, practicality and patient experience of six new technologies that have been designed to reduce levels of infection, especially MRSA bloodstream infections and C. difficile.
Our showcase project manager, Anthony Sewell, said: "We are speeding up the time it takes for proven infection prevention technologies to be introduced into a healthcare setting. While our patients will be the first to benefit, the work we are doing will enable hospitals across the country to fight infections like MRSA and C. diff more effectively."
Contact us
Anthony Sewell
Project manager, showcase hospital HCAI technology programme
Imperial College Healthcare NHS Trust
Second floor, Hammersmith House
Hammersmith Hospital
Du Cane Road
London
W12 0HS
T: 020 3313 1558
M: 07920 454329
E: anthonyjohn.sewell@imperial.nhs.uk